The SBI Group has achieved dramatic growth centered around its three major businesses: the Financial Services Business, which includes online securities, banking, and insurance; the Asset Management Business, which primarily invests in venture companies; and the Biotechnology, Healthcare and Medical Informatics Business, which develops and markets pharmaceuticals, health foods, and cosmetics, as well as research and development of new drugs.
Currently, the SBI Group has shifted to the five businesses: "Financial Services Business," "PE Investment Business," "Asset Management Business," "Crypto-asset Business," and " Next Gen Business". To achieve our goal of "going beyond finance with finance as its core," we will continue to focus on providing products and services using advanced technology and creating new business opportunities.